Acrux Limited

Stocks

ACR

AU000000ACR3

Market Closed - Australian S.E. 01:08:00 2026-09-07 EDT			5-day change	1st Jan Change
0.0110 ^AUD	0.00%		+4.76%	-26.67%

08-26	Acrux Limited Reports Earnings Results for the Full Year Ended June 30, 2026	CI
08-24	Acrux Limited Auditor Raises 'Going Concern' Doubt	CI

Transcript : Acrux Limited - Special Call

Published on 08/17/2026 at 03:35 am EDT - Modified on 08/17/2026 at 05:20 am EDT

S&P Capital IQ

Presenter Speech
Unknown Executive (Executives)

Good morning, everyone, and welcome to this investor webinar for Acrux Limited. My name is [ Gaby Holles ]. I assist Acrux with Investor Relations. And

This article is reserved for our subscribers.

To unlock the article,
subscribe!

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

Latest news about Acrux Limited

08-26	Acrux Limited Reports Earnings Results for the Full Year Ended June 30, 2026	CI
08-24	Acrux Limited Auditor Raises 'Going Concern' Doubt	CI
08-24	Acrux Limited Announces Appointment of Jolanta Airey as Chief Medical Officer	CI
08-17	Acrux Limited - Special Call
05-27	Acrux licenses Lenzetto for Australian market for A$5.4 million	RE
05-27	Hungary's Richter and Acrux agree to license transdermal estradiol spray for Australia	RE
05-27	Gedeon Richter Plc. and Acrux Limited Extend License Agreement for Lenzetto® in Australia	CI
05-13	Acrux says capital gains tax exemptions remain in place for Acrux	RE
05-10	Acrux raises A$1.6 mln via at 0.95 au cents per share	RE
05-06	Acrux requests trading halt	RE
02-24	Acrux Limited Reports Earnings Results for the Half Year Ended December 31, 2025	CI
25-08-29	Acrux Limited Reports Earnings Results for the Full Year Ended June 30, 2025	CI
25-08-28	Acrux Ltd posts FY loss attributable of A$5.9 million	RE
25-08-27	Acrux Limited Auditor Raises 'Going Concern' Doubt	CI
25-07-31	Acrux Signs 10-Year Licensing Deal For Dapsone Gel in Saudi Arabia	MT

Chart Acrux Limited

Duration

Period

ACR: Dynamic Chart

Company Profile

Sector

More about the company

Income Statement and Estimates

More financial data